MNKD

MannKind Corporation News Headlines

$6.25
*  
0.14
 negative 
2.19%
Get MNKD Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cramer's Lightning Round - I Am Critical And Skeptical Of MannKind (4/17/14)
4/18/2014 6:14:00 AM - Seeking Alpha

XBI, MNKD, UTHR, ARNA: Large Inflows Detected at ETF
4/17/2014 10:52:14 AM - BNK Invest

The Stalled State Of MannKind
4/11/2014 10:12:00 AM - Seeking Alpha

Why I Believe MannKind Shares Will Rise Significantly Upon FDA Approval Of Afrezza
4/10/2014 10:46:00 AM - Seeking Alpha

Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs
4/8/2014 11:01:00 AM - Seeking Alpha

Company News for April 08, 2014 - Corporate Summary
4/8/2014 10:06:01 AM - Zacks.com

MannKind Slips on Afrezza Approval Delay - Analyst Blog
4/8/2014 8:52:01 AM - Zacks.com

IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR
4/8/2014 12:46:00 AM - RTT News

Closing Update: Wall Street Extends Losing Streak On Worries Over Earnings, Valuation
4/7/2014 4:06:11 PM - MT Newswires

Mid-Afternoon Market Update: Markets Continue to Show Weakness as Defensive Names Come into Favor
4/7/2014 3:46:34 PM - Benzinga

The 27-1 AdCom Votes Have So Many Positive Implications For MannKind
4/7/2014 2:26:00 PM - Seeking Alpha

If MannKind Keeps Pulling Back, It's A Buying Opportunity
4/7/2014 1:57:00 PM - Seeking Alpha

Mid-Day Market Update: Dow Tumbles Over 100 Points; Intel Shares Rise Following Analyst Upgrade
4/7/2014 12:35:47 PM - Benzinga

Stocks Extend Recent Pullback As Earnings Season Looms - U.S. Commentary
4/7/2014 12:19:00 PM - RTT News

Over 91% Chance Of Approval For MannKind And Durata Therapeutics
4/7/2014 12:00:00 PM - Seeking Alpha

MannKind: FDA Delays Afrezza Decision
4/7/2014 11:29:00 AM - Fox Business

Mid-Morning Market Update: Markets Drop; Mallinckrodt To Acquire Questcor Pharmaceuticals For $5.6B
4/7/2014 10:32:36 AM - Benzinga

U.S. Hot Stocks: Hot Stock to Watch
4/7/2014 9:40:00 AM - Dow Jones Business News

Futures Point to Weaker Open as the Sell-Off Continues
4/7/2014 9:19:00 AM - Knobias

Stock Futures Defensive Ahead of Earnings Season
4/7/2014 9:13:24 AM - MT Newswires

Stocks May Extend Recent Pullback In Early Trading - U.S. Commentary
4/7/2014 8:44:00 AM - RTT News

Pre-Market Most Active for Apr 7, 2014 : QQQ, MNKD, QCOR, MNK, FB, VOCS, BAC, PFE, VOD, MTU, RMD, CCL
4/7/2014 8:38:58 AM - NASDAQ.com News

Futures Lower Following Weakness in Asia and Europe
4/7/2014 8:13:00 AM - Knobias

MannKind: FDA Extends PDUFA Date For Afrezza By Three Months To July 15
4/7/2014 4:10:00 AM - RTT News

Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So
4/6/2014 12:22:00 AM - Seeking Alpha